66:
234:
168:
25:
432:
and other emerging infections. DHVI received support from the Dean of the School of
Medicine to recruit new faculty for HIV research and to apply for a Regional Center for Excellence in Emerging Infections and Biodefense grant from the
83:
38:
586:
542:
244:
44:
444:
research facility and a
Regional Biocontainment Laboratory (RBL). Completed in 2006, this building is designed to support basic research and to provide
310:
130:
404:
immune responses and using this information to design vaccines that will induce protective immunity at the time and location of HIV-1 transmission.
282:
102:
289:
109:
258:
of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be
459:-funded Center for HIV/AIDS Vaccine Immunology; a $ 350 million grant to speed the development of an AIDS vaccine was made. This was led by
178:
296:
116:
417:
373:
197:
347:
329:
278:
215:
149:
98:
52:
255:
87:
434:
251:
267:
388:
and other emerging infections. The vaccine strategy of the Duke CHAVI-ID is based on identifying and targeting novel
303:
193:
123:
502:
76:
581:
532:
413:
369:
263:
259:
401:
189:
463:. Over the next 7 years (beginning in 2012), the Duke CHAVI-ID builds on CHAVI to improve
440:
In 2003, the NIH funded the construction of the Duke Global Health
Research Building, an
575:
460:
449:
445:
425:
381:
65:
557:
544:
441:
506:
421:
377:
397:
393:
484:
464:
456:
389:
503:"Overview and History | Duke Human Vaccine Institute (DHVI)"
250:
Please help to demonstrate the notability of the topic by citing
429:
385:
227:
161:
59:
18:
485:"About The Center for HIV-AIDS Vaccine Immunology - CHAVI"
185:
412:
In 1990, the Duke Human
Vaccine Institute, located in
245:
notability guidelines for companies and organizations
196:, and by adding encyclopedic content written from a
90:. Unsourced material may be challenged and removed.
587:Medical research institutes in North Carolina
8:
53:Learn how and when to remove these messages
348:Learn how and when to remove this message
330:Learn how and when to remove this message
279:"Duke University Human Vaccine Institute"
216:Learn how and when to remove this message
150:Learn how and when to remove this message
99:"Duke University Human Vaccine Institute"
420:'s interdisciplinary efforts to develop
476:
177:contains content that is written like
455:In 2005, DHVI became the home to the
7:
88:adding citations to reliable sources
418:Duke University School of Medicine
374:Duke University School of Medicine
14:
34:This article has multiple issues.
232:
166:
64:
23:
243:may not meet Knowledge (XXG)'s
75:needs additional citations for
42:or discuss these issues on the
1:
435:National Institutes of Health
16:Vaccine research organization
362:Duke Human Vaccine Institute
603:
252:reliable secondary sources
241:The topic of this article
416:, was formed to support
372:, was formed to support
558:36.007738°N 78.943262°W
414:Durham, North Carolina
376:'s efforts to develop
370:Durham, North Carolina
563:36.007738; -78.943262
198:neutral point of view
84:improve this article
554: /
392:vulnerabilities to
190:promotional content
448:in the event of a
442:infectious disease
247:
192:and inappropriate
489:chavi-id-duke.org
358:
357:
350:
340:
339:
332:
314:
242:
226:
225:
218:
160:
159:
152:
134:
57:
594:
569:
568:
566:
565:
564:
559:
555:
552:
551:
550:
547:
536:
535:
533:Official website
518:
517:
515:
514:
505:. Archived from
499:
493:
492:
481:
467:vaccine design.
353:
346:
335:
328:
324:
321:
315:
313:
272:
236:
235:
228:
221:
214:
210:
207:
201:
179:an advertisement
170:
169:
162:
155:
148:
144:
141:
135:
133:
92:
68:
60:
49:
27:
26:
19:
602:
601:
597:
596:
595:
593:
592:
591:
582:Duke University
572:
571:
562:
560:
556:
553:
548:
545:
543:
541:
540:
531:
530:
527:
522:
521:
512:
510:
501:
500:
496:
483:
482:
478:
473:
437:(NIH) in 2002.
410:
354:
343:
342:
341:
336:
325:
319:
316:
273:
271:
249:
237:
233:
222:
211:
205:
202:
183:
171:
167:
156:
145:
139:
136:
93:
91:
81:
69:
28:
24:
17:
12:
11:
5:
600:
598:
590:
589:
584:
574:
573:
538:
537:
526:
525:External links
523:
520:
519:
494:
475:
474:
472:
469:
446:surge capacity
409:
406:
368:), located in
356:
355:
338:
337:
240:
238:
231:
224:
223:
194:external links
174:
172:
165:
158:
157:
72:
70:
63:
58:
32:
31:
29:
22:
15:
13:
10:
9:
6:
4:
3:
2:
599:
588:
585:
583:
580:
579:
577:
570:
567:
534:
529:
528:
524:
509:on 2015-06-26
508:
504:
498:
495:
490:
486:
480:
477:
470:
468:
466:
462:
461:Barton Haynes
458:
453:
451:
450:public health
447:
443:
438:
436:
431:
427:
423:
419:
415:
407:
405:
403:
399:
395:
391:
387:
383:
379:
375:
371:
367:
363:
352:
349:
334:
331:
323:
320:February 2019
312:
309:
305:
302:
298:
295:
291:
288:
284:
281: –
280:
276:
275:Find sources:
269:
265:
261:
257:
253:
246:
239:
230:
229:
220:
217:
209:
199:
195:
191:
187:
181:
180:
175:This article
173:
164:
163:
154:
151:
143:
132:
129:
125:
122:
118:
115:
111:
108:
104:
101: –
100:
96:
95:Find sources:
89:
85:
79:
78:
73:This article
71:
67:
62:
61:
56:
54:
47:
46:
41:
40:
35:
30:
21:
20:
539:
511:. Retrieved
507:the original
497:
488:
479:
454:
439:
426:therapeutics
411:
382:therapeutics
365:
361:
359:
344:
326:
317:
307:
300:
293:
286:
274:
212:
203:
188:by removing
184:Please help
176:
146:
137:
127:
120:
113:
106:
94:
82:Please help
77:verification
74:
50:
43:
37:
36:Please help
33:
561: /
452:emergency.
256:independent
206:August 2015
140:August 2015
576:Categories
549:78°56′36″W
546:36°00′28″N
513:2015-06-02
471:References
290:newspapers
264:redirected
186:improve it
110:newspapers
39:improve it
254:that are
45:talk page
422:vaccines
378:vaccines
408:History
402:NK cell
304:scholar
268:deleted
124:scholar
400:, and
306:
299:
292:
285:
277:
260:merged
126:
119:
112:
105:
97:
465:HIV-1
457:NIAID
390:HIV-1
311:JSTOR
297:books
266:, or
131:JSTOR
117:books
428:for
424:and
384:for
380:and
366:DHVI
360:The
283:news
103:news
430:HIV
386:HIV
86:by
578::
487:.
396:,
262:,
48:.
516:.
491:.
398:T
394:B
364:(
351:)
345:(
333:)
327:(
322:)
318:(
308:·
301:·
294:·
287:·
270:.
248:.
219:)
213:(
208:)
204:(
200:.
182:.
153:)
147:(
142:)
138:(
128:·
121:·
114:·
107:·
80:.
55:)
51:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
